Cargando…

CIGB-300-Regulated Proteome Reveals Common and Tailored Response Patterns of AML Cells to CK2 Inhibition

Protein kinase CK2 is a highly pleiotropic and ubiquitously expressed Ser/Thr kinase with instrumental roles in normal and pathological states, including neoplastic phenotype in solid tumor and hematological malignancies. In line with previous reports, CK2 has been suggested as an attractive prognos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosales, Mauro, Rodríguez-Ulloa, Arielis, Pérez, George V., Besada, Vladimir, Soto, Thalia, Ramos, Yassel, González, Luis J., Zettl, Katharina, Wiśniewski, Jacek R., Yang, Ke, Perera, Yasser, Perea, Silvio E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962202/ https://www.ncbi.nlm.nih.gov/pubmed/35359604 http://dx.doi.org/10.3389/fmolb.2022.834814

Ejemplares similares

Targeting of Protein Kinase CK2 in Acute Myeloid Leukemia Cells Using the Clinical-Grade Synthetic-Peptide CIGB-300
por: Rosales, Mauro, et al.
Publicado: (2021)

Phosphoproteomic Landscape of AML Cells Treated with the ATP-Competitive CK2 Inhibitor CX-4945
por: Rosales, Mauro, et al.
Publicado: (2021)

CIGB-300 Anticancer Peptide Differentially Interacts with CK2 Subunits and Regulates Specific Signaling Mediators in a Highly Sensitive Large Cell Lung Carcinoma Cell Model
por: Pérez, George V., et al.
Publicado: (2022)

Gene expression profiling unveils the temporal dynamics of CIGB-300-regulated transcriptome in AML cell lines
por: Vázquez-Blomquist, Dania, et al.
Publicado: (2023)

Preclinical efficacy of CIGB-300, an anti-CK2 peptide, on breast cancer metastasic colonization
por: Gottardo, Maria F., et al.
Publicado: (2020)

Targeting chronic lymphocytic leukemia using CIGB-300, a clinical-stage CK2-specifc cell-permeable peptide inhibitor
por: Martins, Leila R., et al.
Publicado: (2013)

Proteomic Study to Survey the CIGB-552 Antitumor Effect
por: Rodríguez-Ulloa, Arielis, et al.
Publicado: (2015)

CIGB-300 Peptide Targets the CK2 Phospho-Acceptor Domain on Human Papillomavirus E7 and Disrupts the Retinoblastoma (RB) Complex in Cervical Cancer Cells
por: Ramón, Ailyn C., et al.
Publicado: (2022)

Targeting of Protein Kinase CK2 Elicits Antiviral Activity on Bovine Coronavirus Infection
por: Ramón, Ailyn C., et al.
Publicado: (2022)

Data for comparative proteomics analysis of the antitumor effect of CIGB-552 peptide in HT-29 colon adenocarcinoma cells
por: Núñez de Villavicencio-Díaz, Teresa, et al.
Publicado: (2015)

Optimizing CIGB-300 intralesional delivery in locally advanced cervical cancer
por: Sarduy, M R, et al.
Publicado: (2015)

The synthetic peptide CIGB-300 modulates CK2-dependent signaling pathways affecting the survival and chemoresistance of non-small cell lung cancer cell lines
por: Cirigliano, Stéfano M., et al.
Publicado: (2017)

CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disorders
por: Baier, Andrea, et al.
Publicado: (2022)

Predicting CK2 beta-dependent substrates using linear patterns
por: Núñez de Villavicencio-Díaz, Teresa, et al.
Publicado: (2015)

Mechanism of CK2 Inhibition by a Ruthenium-Based Polyoxometalate
por: Fabbian, Simone, et al.
Publicado: (2022)

Copper Modulates the Catalytic Activity of Protein Kinase CK2
por: Chojnowski, John E., et al.
Publicado: (2022)

The protein kinase CK1: Inhibition, activation, and possible allosteric modulation
por: Sunkari, Yashoda Krishna, et al.
Publicado: (2022)

Comprehensive Characterization of CK1δ-Mediated Tau Phosphorylation in Alzheimer’s Disease
por: Roth, Aileen, et al.
Publicado: (2022)

CK2β Is a Gatekeeper of Focal Adhesions Regulating Cell Spreading
por: Filhol, Odile, et al.
Publicado: (2022)

Clinical-Grade Peptide-Based Inhibition of CK2 Blocks Viability and Proliferation of T-ALL Cells and Counteracts IL-7 Stimulation and Stromal Support
por: Perera, Yasser, et al.
Publicado: (2020)

The Okur-Chung Neurodevelopmental Syndrome Mutation CK2(K198R) Leads to a Rewiring of Kinase Specificity
por: Caefer, Danielle M., et al.
Publicado: (2022)

Inhibition of Protein Kinase CK2 Affects Thymidylate Synthesis Cycle Enzyme Level and Distribution in Human Cancer Cells
por: Wińska, Patrycja, et al.
Publicado: (2022)

Structural and Enzymological Evidence for an Altered Substrate Specificity in Okur-Chung Neurodevelopmental Syndrome Mutant CK2α(Lys198Arg)
por: Werner, Christian, et al.
Publicado: (2022)

Implementing a Scoring Function Based on Interaction Fingerprint for Autogrow4: Protein Kinase CK1δ as a Case Study
por: Pavan, Matteo, et al.
Publicado: (2022)

Editorial: Tailored Modulation of Interactions Between Biomolecules: Fundamentals and Applications
por: Ardini, Matteo, et al.
Publicado: (2022)

Comparing Two Neurodevelopmental Disorders Linked to CK2: Okur-Chung Neurodevelopmental Syndrome and Poirier-Bienvenu Neurodevelopmental Syndrome—Two Sides of the Same Coin?
por: Ballardin, Demetra, et al.
Publicado: (2022)

Protein and Organic-Molecular Crystallography With 300kV Electrons on a Direct Electron Detector
por: Takaba, Kiyofumi, et al.
Publicado: (2021)

In-silico probing of AML related RUNX1 cancer-associated missense mutations: Predicted relationships to DNA binding and drug interactions
por: Ullah, Hanif, et al.
Publicado: (2022)

Tailoring the Variational Implicit Solvent Method for New Challenges: Biomolecular Recognition and Assembly
por: Ricci, Clarisse Gravina, et al.
Publicado: (2018)

Corrigendum: Protein and Organic-Molecular Crystallography with 300kV Electrons on a Direct Electron Detector
por: Takaba, Kiyofumi, et al.
Publicado: (2021)

The Antitumor Peptide CIGB-552 Increases COMMD1 and Inhibits Growth of Human Lung Cancer Cells
por: Fernández Massó, Julio R., et al.
Publicado: (2013)

The Anticancer Peptide CIGB-552 Exerts Anti-Inflammatory and Anti-Angiogenic Effects through COMMD1
por: Daghero, Hellen, et al.
Publicado: (2020)

Proteomics and Phospho-Proteomics Profiling of the Co-Formulation of Type I and II Interferons, HeberFERON, in the Glioblastoma-Derived Cell Line U-87 MG
por: Vázquez-Blomquist, Dania, et al.
Publicado: (2022)

Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in COVID-19 Patients with Pneumonia. A Randomized and Controlled Clinical Trial
por: Cruz, Leticia R., et al.
Publicado: (2020)

Datasets: Sensitivity and protein digestion course of proteomic Filter Aided Sample Preparation
por: Wiśniewski, Jacek R., et al.
Publicado: (2019)

Epigenetic Therapy Promotes the Ratio of Th1/Th17 Lineage to Reverse Immune Evasion and Treat Leukemia Relapse Post-allogeneic Stem Cell Transplantation in Non-APL AML Patients
por: Xi, Yang, et al.
Publicado: (2021)

Cell Penetrating Capacity and Internalization Mechanisms Used by the Synthetic Peptide CIGB-552 and Its Relationship with Tumor Cell Line Sensitivity
por: Astrada, Soledad, et al.
Publicado: (2018)

CIGB-258, a peptide derived from human heat-shock protein 60, decreases hyperinflammation in COVID-19 patients
por: Hernandez-Cedeño, M., et al.
Publicado: (2021)

HEPATITIS B NUCLEOCAPSID PARTICLE AS IMMUNOPOTENTIATOR OF INNATE AND ADAPTIVE IMMUNITY FOR NASAL VACCINES CIGB 2020 AND MAMBISA AGAINST COVID-19
por: Guillen, G., et al.
Publicado: (2023)

Macro-CK and CK-BB Contributing to Sham CK-MB Elevation
por: Wada, Yuki, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_oe1c6f7a5abnl7hubirvm3sbs0